Drug profile · INN
esaxerenone
MINNEBRO
esaxerenone (MINNEBRO) is a mineralocorticoid receptor antagonist.
PMDA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — esaxerenone
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.78
Quick answer
esaxerenone (MINNEBRO) is a mineralocorticoid receptor antagonist.
Key facts
INN esaxerenone
Brand MINNEBRO
Mechanism Mineralocorticoid receptor antagonist
Target Mineralocorticoid receptor
Mechanism of action
Mineralocorticoid receptor antagonist
Primary target: Mineralocorticoid receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| PMDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is esaxerenone?
esaxerenone (MINNEBRO) is a mineralocorticoid receptor antagonist.
What is the brand name for esaxerenone?
MINNEBRO is a marketed brand name for esaxerenone. Check FDA Drugs@FDA for the current US label holder and prescribing information.